Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers

被引:1
|
作者
Thatipamula, R. P. [1 ]
Palem, C. R. [1 ]
Gannu, R. [1 ]
Mudragada, S. [1 ]
Yamsani, M. R. [1 ]
机构
[1] Kakatiya Univ, Univ Coll Pharmaceut Sci, Natl Facil Engn & Technol Ind Collaborat NAFETIC, Warangal 506009, Andhra Pradesh, India
关键词
Entrapment efficiency; Polydispersity index; DSC; TEM; EX-VIVO CHARACTERIZATION; SLN; CYTOTOXICITY; DELIVERY; MATRIX; NLC;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and the purpose of the study: Domperidone (DOM) is a dopamine- receptor (D-2) antagonist, widely used in the treatment of motion-sickness. The pharmacokinetic parameters of DOM make it a suitable candidate for development of Solid Lipid Nanoparticle (SLN) and Nanostructured Lipide Carrier (NLC). The purpose of the present investigation was to prepare and evaluate DOM loaded solid lipid nanoparticles (DOM-SLN) and DOM loaded nanostructured lipid carriers (DOM-NLC). Methods: DOM loaded SLN and NLC were prepared by hot homogenization followed by ultrasonication technique, using trimyristin as solid lipid, cetyl recinoleate as liquid lipid and a mixture of soy phosphatidylcholine (99%) and tween 80 as surfactant. SLN and NLC were characterized for particle size, polydispersity index (Pal), zeta potential and entrapment efficiency. The effects of composition of lipid materials and surfactant mixture on the particle size, PDI, zeta potential, drug entrapment efficiency, and in vitro drug release behavior were investigated. DSC analysis was performed to characterize the state of drug and lipid modification. Shape and surface morphology were determined by transmission electron microscopy (TEM). SLN and NLC formulations were subjected to stability study over a period of 40 days. Results: The mean particle size, PDI, zeta potential and entrapment efficiency of optimized SLN (SLN1) and NLC were found to be 30.45 nm, 0.156, 12.40 mV, 87.84% and 32.23 nm, 0.160, 10.47 mV, 90.49 % respectively. DSC studies revealed that DOM was in an amorphous state and triglycerides were in the 13 prime form in SLN and NLC. Shape and surface morphology was determined by TEM revealed fairly spherical shape of nanoparticles. In vitro release studies demonstrated that both the SLN and NLC formulations possessed a controlled release over a period of 24 hrs. SLN and NLC formulations were subjected to stability over a period of 40 days. There was no significant (P < 0.05) change in particle size, zeta potential, PDI and entrapment efficiency indicating the developed SLN and NLC were fairly stable. Conclusion: Fairly spherical shaped, stable and controlled release DOM-SLN and DOM-NLC could be prepared by hot homogenization followed by ultrasonication technique.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 50 条
  • [1] Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation
    Scioli Montoto, S.
    Sbaraglini, M. L.
    Talevi, A.
    Couyoupetrou, M.
    Di Ianni, M.
    Pesce, G. O.
    Alvarez, V. A.
    Bruno-Blanch, L. E.
    Castro, G. R.
    Ruiz, M. E.
    Islan, G. A.
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 167 : 73 - 81
  • [2] Formulation and Evaluation of Nisoldipine Loaded Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Application to Transdermal Delivery
    Shirisha, Suddala
    Saraswathi, Ankam
    Sahoo, Sunit Kumar
    Rao, Yamsani Madhusudan
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2020, 54 (02) : S117 - S127
  • [3] Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
    Gonullu, Umit
    Uner, Melike
    Yener, Gulgun
    Karaman, Ecem Fatma
    Aydogmus, Zeynep
    [J]. ACTA PHARMACEUTICA, 2015, 65 (01) : 1 - 13
  • [4] Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers
    Li, Fang
    Wang, Yanjiao
    Liu, Zitong
    Lin, Xia
    He, Haibing
    Tang, Xing
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (05) : 508 - 517
  • [5] Effects of Chloramphenicol on the Characterization of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
    Li, Zhen
    Lin, Xiaohong
    Yu, Li
    Li, Xinwei
    Geng, Fei
    Zheng, Liqiang
    [J]. JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2009, 30 (07) : 1008 - 1014
  • [6] Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers
    Kuo, Yung-Chih
    Chung, Jui-Fang
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 83 (02) : 299 - 306
  • [7] Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization
    Shazly, Gamal A.
    Alshehri, Sultan
    Ibrahim, Mohamed A.
    Tawfeek, Hesham M.
    Razik, Jelan A.
    Hassan, Yasser A.
    Shakeel, Faiyaz
    [J]. AAPS PHARMSCITECH, 2018, 19 (04): : 1712 - 1719
  • [8] Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization
    Gamal A. Shazly
    Sultan Alshehri
    Mohamed A. Ibrahim
    Hesham M. Tawfeek
    Jelan A. Razik
    Yasser A. Hassan
    Faiyaz Shakeel
    [J]. AAPS PharmSciTech, 2018, 19 : 1712 - 1719
  • [9] Preparation, characterization and evaluation of physicochemical properties of phycocyanin-loaded solid lipid nanoparticles and nanostructured lipid carriers
    Yagoubi, Amin Seyed
    Shahidi, Fakhri
    Mohebbi, Mohebbat
    Varidi, Mehdi
    Golmohammadzadeh, Shiva
    [J]. JOURNAL OF FOOD MEASUREMENT AND CHARACTERIZATION, 2018, 12 (01) : 378 - 385
  • [10] Preparation, characterization and evaluation of physicochemical properties of phycocyanin-loaded solid lipid nanoparticles and nanostructured lipid carriers
    Amin Seyed Yagoubi
    Fakhri Shahidi
    Mohebbat Mohebbi
    Mehdi Varidi
    Shiva Golmohammadzadeh
    [J]. Journal of Food Measurement and Characterization, 2018, 12 : 378 - 385